Atsushi Ose

766 total citations
18 papers, 601 citations indexed

About

Atsushi Ose is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Atsushi Ose has authored 18 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Molecular Biology. Recurrent topics in Atsushi Ose's work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Bone health and treatments (4 papers). Atsushi Ose is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Bone health and treatments (4 papers). Atsushi Ose collaborates with scholars based in Japan. Atsushi Ose's co-authors include Yuichi Sugiyama, Hiroyuki Kusuhara, Yasuhiro Masubuchi, Toshiharu Horie, Junichi Enokizono, Alfred H. Schinkel, Masakatsu Shibasaki, Kenzo Yamatsugu, Motomu Kanai and Satoshi Kitamura and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Osteoporosis International and Drug Metabolism and Disposition.

In The Last Decade

Atsushi Ose

18 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsushi Ose Japan 10 346 182 129 128 92 18 601
Paresh P. Chothe United States 14 299 0.9× 139 0.8× 129 1.0× 178 1.4× 61 0.7× 34 571
Kazumasa Naruhashi Japan 15 321 0.9× 172 0.9× 94 0.7× 181 1.4× 59 0.6× 30 706
Peng Hsiao United States 11 465 1.3× 316 1.7× 111 0.9× 127 1.0× 21 0.2× 12 698
Birgitta Noé Germany 8 574 1.7× 302 1.7× 97 0.8× 213 1.7× 61 0.7× 8 827
Hiroshi Suzuki Japan 12 622 1.8× 391 2.1× 164 1.3× 94 0.7× 33 0.4× 13 740
Yusuke Masuo Japan 17 394 1.1× 82 0.5× 150 1.2× 298 2.3× 175 1.9× 41 890
Osamu Tagaya Japan 11 364 1.1× 262 1.4× 108 0.8× 151 1.2× 65 0.7× 24 605
Ralph E. Davidson United States 6 391 1.1× 218 1.2× 124 1.0× 204 1.6× 15 0.2× 6 649
Jean-Pierre Raufman United States 18 404 1.2× 68 0.4× 143 1.1× 482 3.8× 137 1.5× 28 1.1k
K.‐Fr. Sewing Germany 15 164 0.5× 201 1.1× 139 1.1× 303 2.4× 44 0.5× 58 980

Countries citing papers authored by Atsushi Ose

Since Specialization
Citations

This map shows the geographic impact of Atsushi Ose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Ose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Ose more than expected).

Fields of papers citing papers by Atsushi Ose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Ose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Ose. The network helps show where Atsushi Ose may publish in the future.

Co-authorship network of co-authors of Atsushi Ose

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Ose. A scholar is included among the top collaborators of Atsushi Ose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Ose. Atsushi Ose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ose, Atsushi, et al.. (2023). Population Pharmacokinetics, Exposure–Safety, and Probability of Target Attainment Analyses for Isavuconazole in Japanese Patients With Deep‐Seated Mycoses. The Journal of Clinical Pharmacology. 63(6). 704–714. 5 indexed citations
2.
Ose, Atsushi, et al.. (2022). Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese Subjects. Clinical Pharmacology in Drug Development. 11(6). 744–753. 7 indexed citations
3.
Mori, Yoko, et al.. (2022). A Pharmacokinetic Bioequivalence Study Comparing Different‐Strength and ‐Size Capsules of Isavuconazonium Sulfate in Healthy Japanese Subjects. Clinical Pharmacology in Drug Development. 11(9). 1092–1098. 4 indexed citations
4.
Kasai, Hidefumi, Yoko Mori, Atsushi Ose, Masataka Shiraki, & Yusuke Tanigawara. (2020). Prediction of Fracture Risk From Early‐Stage Bone Markers in Patients With Osteoporosis Treated With Once‐Yearly Administered Zoledronic Acid. The Journal of Clinical Pharmacology. 61(5). 606–613. 6 indexed citations
5.
Kumagai, Yuji, Atsushi Ose, Kosuke Tanaka, & Toshitsugu Sugimoto. (2019). Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice‐Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single‐Blind Randomized Study. Clinical Pharmacology in Drug Development. 9(1). 87–96. 7 indexed citations
6.
7.
Ose, Atsushi, et al.. (2017). Population Pharmacokinetic and Exposure–Response Analysis of Weekly Teriparatide in Osteoporosis Patients. The Journal of Clinical Pharmacology. 57(12). 1545–1553. 3 indexed citations
8.
Ose, Atsushi, Kota Toshimoto, Kazushi Ikeda, et al.. (2016). Development of a Support Vector Machine-Based System to Predict Whether a Compound Is a Substrate of a Given Drug Transporter Using Its Chemical Structure. Journal of Pharmaceutical Sciences. 105(7). 2222–2230. 12 indexed citations
9.
Kusuhara, Hiroyuki, Atsushi Ose, Tsunenori Kondo, et al.. (2016). Pharmacokinetic Modeling and Monte Carlo Simulation to Predict Interindividual Variability in Human Exposure to Oseltamivir and Its Active Metabolite, Ro 64-0802. The AAPS Journal. 19(1). 286–297. 6 indexed citations
10.
Yamashita, Fumiyoshi, et al.. (2013). Automated Extraction of Information on Chemical–P-glycoprotein Interactions from the Literature. Journal of Chemical Information and Modeling. 53(10). 2506–2510. 2 indexed citations
11.
Ito, Sumito, Atsushi Ose, Yoshiaki Kitamura, et al.. (2013). Relationship Between the Urinary Excretion Mechanisms of Drugs and Their Physicochemical Properties. Journal of Pharmaceutical Sciences. 102(9). 3294–3301. 19 indexed citations
12.
Ose, Atsushi, et al.. (2009). Functional Characterization of Mouse Organic Anion Transporting Peptide 1a4 in the Uptake and Efflux of Drugs Across the Blood-Brain Barrier. Drug Metabolism and Disposition. 38(1). 168–176. 123 indexed citations
13.
Enokizono, Junichi, Hiroyuki Kusuhara, Atsushi Ose, Alfred H. Schinkel, & Yuichi Sugiyama. (2008). Quantitative Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting Brain and Testis Penetration of Xenobiotic Compounds. Drug Metabolism and Disposition. 36(6). 995–1002. 116 indexed citations
14.
15.
Ose, Atsushi, Hiroyuki Kusuhara, Kenzo Yamatsugu, et al.. (2007). P-glycoprotein Restricts the Penetration of Oseltamivir Across the Blood-Brain Barrier. Drug Metabolism and Disposition. 36(2). 427–434. 79 indexed citations
16.
Masubuchi, Yasuhiro, Atsushi Ose, & Toshiharu Horie. (2002). Diclofenac-Induced Inactivation of CYP3A4 and Its Stimulation by Quinidine. Drug Metabolism and Disposition. 30(10). 1143–1148. 41 indexed citations
17.
Masubuchi, Yasuhiro, et al.. (2001). Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver. Archives of Toxicology. 75(9). 538–543. 28 indexed citations
18.
Masubuchi, Yasuhiro, Atsushi Ose, & Toshiharu Horie. (2001). Mechanism-based inactivation of CYP2C11 by diclofenac.. PubMed. 29(9). 1190–5. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paresh P. Chothe Breakdown of academic impact, for papers by Kazumasa Naruhashi Breakdown of academic impact, for papers by Peng Hsiao Breakdown of academic impact, for papers by Birgitta Noé Breakdown of academic impact, for papers by Hiroshi Suzuki Breakdown of academic impact, for papers by Yusuke Masuo Breakdown of academic impact, for papers by Osamu Tagaya Breakdown of academic impact, for papers by Ralph E. Davidson Breakdown of academic impact, for papers by Jean-Pierre Raufman Breakdown of academic impact, for papers by K.‐Fr. Sewing
Rankless by CCL
2026